The Lovenox trial schedule was not determined by mutual agreement between Teva and NVS/MNTA; rather, the schedule was set by the Court itself. This was asked and answered at MNTA’s annual meeting in June (#msg-64248348).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.